CSIR Central

Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Sashidhara, K V
Avula, S R
Sharma, Komal
Palnati, G R
Bathula, S R
 
Date 2013-03-07T11:02:27Z
2013-03-07T11:02:27Z
2013
 
Identifier Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent
http://hdl.handle.net/123456789/1025
 
Description Development of new, targeted antibreast cancer drug which can treat both the hormone receptor (positive and negative) breast cancers is a very challenging task. The concept of molecular hybridization led us to discover a novel class of coumarin-monastrol hybrid, as a novel breast cancer agent which selectively induce apoptosis in both primary and metastatic breast cancer cell lines.
 
Format 367910 bytes
application/pdf
 
Language en
 
Relation C.D.R.I. Communication No. 8364
 
Subject Coumarin
Monastrol
Hybrids
Antibreast tumor
 
Title Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent
 
Type Article